articleTop 10% cited
Discrete sequential boundaries for clinical trials
Biometrika · 1983 · Vol. 70(3) · pp. 659–663
K. K. Gordon Lan✉(National Heart Lung and Blood Institute)David L. DeMets(University of Wisconsin System)
Abstract
Pocock (1977), O'Brien & Fleming (1979) and Slud & Wei (1982) have proposed different methods to construct discrete sequential boundaries for clinical trials. These methods require that the total number of decision times be specified in advance. In the present paper, we propose a more flexible way to construct discrete sequential boundaries. The method is based on the choice of a function, α*(t), which characterizes the rate at which the error level α is spent. The boundary at a decision time is determined by α*(t), and by past and current decision times, but does not depend on the future decision times or the total number of decision times.
Statistical Methods in Clinical TrialsOptimal Experimental Design MethodsHealth Systems, Economic Evaluations, Quality of LifeConstruct (python library)MathematicsBoundary (topology)Function (biology)Decision boundaryCurrent (fluid)Discrete time and continuous timeDecision theoryStatisticsMathematical optimization
Citations
1,735
FWCI
7.11
field-weighted impact
References
10
Percentile
97%
vs. same field & year
Citations per year
Cited by
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
Journal of Clinical Oncology · 2007 · 2,267 citations
Apparently conclusive meta-analyses may be inconclusive—Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses
International Journal of Epidemiology · 2008 · 946 citations
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
International Journal of Epidemiology · 2008 · 858 citations
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
JAMA · 2002 · 5,671 citations
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
The Lancet Oncology · 2009 · 2,624 citations
Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses
Journal of Clinical Epidemiology · 2008 · 1,153 citations
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
New England Journal of Medicine · 1999 · 9,024 citations
Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17
JNCI Journal of the National Cancer Institute · 2005 · 1,117 citations
References
A Multiple Testing Procedure for Clinical Trials
Biometrics · 1979 · 3,326 citations
Group sequential methods in the design and analysis of clinical trials
Biometrika · 1977 · 1,771 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
